← Back to news
NewsTHER ADV RARE DISTuesday, December 1, 2026 · -220 days ago

Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy

WHY IT MATTERS

Recent peer-reviewed research relevant to rare disease diagnosis or treatment.

Published in Ther Adv Rare Dis. Mitha A et al.

Read on PubMed
Read the original at Ther Adv Rare Dis
ResearchPubMed

Related conditions

Spinal muscular atrophy associated with central nervous system anomalySpinal muscular atrophy with respiratory distress type 2Spinal muscular atrophy with respiratory distress type 1

Related news

Int J Circumpolar Health · -250 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Health Inf Sci Syst · -220 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
Mol Ther Nucleic Acids · -52 days ago
The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena
Published in Mol Ther Nucleic Acids. Giangrande PH et al.
Surg Pract Sci · -37 days ago
Surgical training program of parathyroidectomy for residents in a national center: a cohort of 122 cases
Published in Surg Pract Sci. Liu Q et al.